IRIS
BIONDI, BERNADETTE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.390
AS - Asia 9.315
EU - Europa 5.438
SA - Sud America 1.090
Continente sconosciuto - Info sul continente non disponibili 371
AF - Africa 239
OC - Oceania 22
AN - Antartide 1
Totale 25.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.013
SG - Singapore 4.604
RU - Federazione Russa 2.299
CN - Cina 1.495
VN - Vietnam 1.296
HK - Hong Kong 944
BR - Brasile 868
IT - Italia 748
FR - Francia 433
UA - Ucraina 351
FI - Finlandia 323
IE - Irlanda 301
DE - Germania 299
SE - Svezia 222
CA - Canada 210
JP - Giappone 165
IN - India 163
GB - Regno Unito 151
NL - Olanda 129
BD - Bangladesh 112
AR - Argentina 85
MX - Messico 81
PK - Pakistan 66
TR - Turchia 60
IQ - Iraq 58
PH - Filippine 51
ZA - Sudafrica 51
ID - Indonesia 40
EG - Egitto 37
TH - Thailandia 36
CO - Colombia 34
EC - Ecuador 32
KR - Corea 32
PL - Polonia 28
TW - Taiwan 27
ES - Italia 25
SA - Arabia Saudita 22
JM - Giamaica 21
JO - Giordania 20
MA - Marocco 20
AT - Austria 19
VE - Venezuela 19
CI - Costa d'Avorio 18
CZ - Repubblica Ceca 18
UZ - Uzbekistan 17
AU - Australia 15
KE - Kenya 15
UY - Uruguay 15
NP - Nepal 14
CL - Cile 13
PY - Paraguay 13
DZ - Algeria 12
NG - Nigeria 12
ET - Etiopia 11
RO - Romania 11
CR - Costa Rica 10
MY - Malesia 10
HU - Ungheria 9
IR - Iran 9
LT - Lituania 9
PE - Perù 9
PS - Palestinian Territory 9
TN - Tunisia 9
AZ - Azerbaigian 8
TT - Trinidad e Tobago 8
HN - Honduras 7
IL - Israele 7
LY - Libia 7
PR - Porto Rico 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
BS - Bahamas 6
DO - Repubblica Dominicana 6
NI - Nicaragua 6
PT - Portogallo 6
SI - Slovenia 6
CM - Camerun 5
GE - Georgia 5
GR - Grecia 5
LV - Lettonia 5
OM - Oman 5
SN - Senegal 5
BY - Bielorussia 4
CY - Cipro 4
DK - Danimarca 4
EU - Europa 4
KZ - Kazakistan 4
LB - Libano 4
MK - Macedonia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BJ - Benin 3
BZ - Belize 3
CG - Congo 3
CH - Svizzera 3
GT - Guatemala 3
KG - Kirghizistan 3
MN - Mongolia 3
MO - Macao, regione amministrativa speciale della Cina 3
NA - Namibia 3
Totale 25.426
Salva come PNG Salva come JPEG
Città #
Singapore 2.064
San Jose 1.468
Hong Kong 923
Moscow 563
Chandler 550
Ashburn 541
The Dalles 413
Jacksonville 363
Ho Chi Minh City 358
Millbury 356
Lauterbourg 292
Princeton 287
Santa Clara 282
Beijing 272
Hanoi 267
Nanjing 267
Los Angeles 223
Naples 179
Boston 164
Council Bluffs 161
Buffalo 152
Tokyo 149
Wilmington 128
Hefei 126
Woodbridge 124
Ottawa 114
New York 107
Amsterdam 104
Phoenix 96
Redondo Beach 92
Napoli 87
Houston 74
Dallas 73
São Paulo 73
Nanchang 71
Da Nang 64
Ann Arbor 59
Shenyang 54
Des Moines 52
Chicago 51
Haiphong 51
Norwalk 49
Munich 46
Atlanta 44
Dong Ket 44
Kronberg 43
Seattle 43
Lahore 40
Hebei 38
Jiaxing 38
Orem 37
Changsha 36
Mexico City 36
Brooklyn 34
Falls Church 32
Montreal 32
San Francisco 32
Afragola 31
Lawrence 31
Denver 27
Dublin 27
Tianjin 27
Boardman 25
Frankfurt am Main 25
Johannesburg 25
Rio de Janeiro 25
Baghdad 24
Belo Horizonte 24
Milan 24
Rome 24
Chennai 23
Toronto 22
Brasília 21
Hải Dương 21
Kunming 21
Memphis 21
Mumbai 20
Nuremberg 20
Helsinki 19
London 18
Stockholm 18
Amman 17
Biên Hòa 17
Bangkok 16
Cairo 16
Durham 16
Manchester 16
Seoul 16
Poplar 15
Shanghai 15
Brno 14
Thái Nguyên 14
Curitiba 13
Dhaka 13
Montevideo 13
Nairobi 13
Thái Bình 13
Turku 13
Warsaw 13
Cagliari 12
Totale 13.356
Salva come PNG Salva come JPEG
Nome #
Critical Approach to Hypothyroid Patients With Persistent Symptoms 496
Levo-thyroxine Replacement in Obese Adults: the Role of Metabolic Variables and Aging on Thyroid Testing Abnormalities. 297
Thyroid and obesity: an intriguing relationship 264
Control of adrenergic overactivity by beta-blockade improves quality of life in patients on long-term suppressive therapy with levo-thyroxine. 237
Impact of hyperthyroidism and its correction on vascular reactivity in humans. 167
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE). 164
Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk Thyroid Cancer Patients. 162
Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart. 146
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 144
Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly 143
Efficacy and safety of radiofrequency thermal ablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. 140
A new marker for diagnosis of thyroid papillary cancer: B-flow twinkling sign. 135
Cardiac effects of GH 134
Recombinant Human Thyroid Stimulating Hormone Improves Endothelial Coronary Flow Reserve in Thyroidectomized Patients With Differentiated Thyroid Cancer 132
Thyrotropin (tsh) directly and acutely affects vascular reactivity in humans 131
Enhancement of vascular endothelial function by recombinant human thyrotropin 127
Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency 127
Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications 125
Gender differences in the prevalence, clinical features and response tro cabergoline in hyperprolactinemia 122
Enhancement of vascular endothelial function by recombinant human thyrotropin. 121
Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation 119
Subclinical hyperthyroidism: clinical features and treatment options. 118
Severe hypothyroidism due to the loss of therapeutic efficacy of L-thyroxine in a patient with esophageal complication associated with systemic sclerosis 118
INCREASED ARTERIAL INTIMA-MEDIA THICKNESS IN CHILDHOOD-ONSET GROWTH HORMONE DEFICIENCY. 117
Thyroid B-flow twinkling sign: a new feature of papillary cancer 117
Impairment of lung volumes and respiratory muscle strength in adult patients with growth hormone deficiency 117
Is the Isthmus Location an Additional Risk Factor for Indeterminate Thyroid Nodules? Case Report and Review of the Literature. 117
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas 116
How do etiological factors can explain the different clinical features of patients with differentiated thyroid cancer and their histopathological findings? 116
New therapeutic strategies in gastroenteropancreatic neuroendocrine tumours 115
PAX8 is expressed in anaplastic thyroid carcinoma diagnosed by fine-needle aspiration: a study of three cases with histological correlates. 114
heart failure caused by dilated cardiomyopathy : rationale for treatment with growth hormone. 110
Fertility in 32 patients receiving 131 I therapy for thyroid cancer 110
Subclinical hypothyroidism in older individuals. 109
Identical HLA antigens in two sisters with MEN IIA syndrome. J Endocrinol Invest. 1994 Mar;17(3):205-6. 109
Flow Cytometry Phenotypization of Intrathyroidal Lymphoid Infiltrate and Thyroidal Functional Status in Hashimoto Thyroiditis on Fine-Needle Cytology Samples 109
Patients with subclinical Cushing’s syndrome have increased cardiovascular risk 106
The risk of thyroid cancer related to the Vesuvius in the region of Campania, Italy 106
Usefulness of 111In-Octreotide scintigraphy in Von-Hippel-Lindau disease. 106
“Ruolo della PET (tomografia ad emissione di positroni) con 2-(18F)Fluoro-2-Desossiglucosio (FDG) nel carcinoma differenziato della tiroide” 104
Impact of hyperthyroidism and its correction on vascular reactivity in humans . 102
Cardovascular safety of acute recombinant human thyrotropin administration in patients monitored for differentiated thyroid cancer. 100
Impact of pituitary adenomas on the heart. Pituitary tumors: Epidemiology, Pathogenesis and Management : 100
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine 100
Maternal thyroid parameters, body mass index and subsequent weight gain during pregnancy in healthy euthyroid women. 99
The role of the GH-IGF-I axis in the regulation of myocardial growth: from experimental models to human evidence. 99
Beneficial effect of doxazosin versus pheonoxibenzamine in pre-operative management of patients with pheochrmocitoma 99
Combination treatment with T4 and T3: Toward personalized replacement therapy in hypothyroidism? 99
Hypothyroidism as a risk factor for cardiovascular disease. 98
Utilizzo del TSH ricombinante nella diagnostica del carcinoma differenziato della tiroide:trials multicentrici di validazione 98
The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril . 97
Cardiovascular involvement in patients with different causes of hyperthyroidism. 97
A preliminary study of growth hormone in the treatment of heart failure in patients with dilated cardiomyopathy. 95
The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism 95
Clinical case seminar: Reentrant atrioventricular nodal tachycardia induced by levothyroxine. 94
Multimetastatic medullary thyroid carcinoma to the breast: PET/CT--mammographic-US and MR findings. 94
Thyroid Hormone Suppression Therapy 94
Effects of thyroid hormone on the cardiovascular system. 92
Thyroid hormone therapy for hypothyroidism. 92
Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. 92
Role of the neck ultrasonography, of thyroglobulin after rhTSH and of FDGPET in post surgical follow-up of differentiated thyroid cancer 91
Benefits of thyrotropin suppression versus the risks of adverse effects 90
Longitudinal study of thyroid autoimmunity and function, before, during and after recombinant interferone alfa-2a (fIFN -2a) therapy. 90
Organizzatrice del Symposio satellite “ The cardiovascular risk at the various stages of the thyroid failure”, 31st European Thyroid Association Meeting 89
“Effetti cardiovascolari delle patologie subcliniche della tiroide”. Aggiornamento di Endocrinologia di Franco Orio e Francesco Orio. Giuseppe De Nicola editore 89
Treatment With Thyroid Hormone. 89
The normal TSH reference range: what has changed in the last decade? 89
Endogenous subclinical hyperthyroidism: who, when and why to treat 88
Cardiac effects of long-term thyrotropin suppressive therapy with levothyroxine. 88
Invited lecture, ETA-CRN Meeting Presentation title: “TSH suppression and the heart”. 88
Effects of subclinical thyroid dysfunction on the heart. 87
Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. 87
Spindle epithelial tumor with thymus-like differentiation (SETTLE): clinical-pathological features, differential pathological diagnosis and therapy. 87
Impact of pituitary adenomas on the heart. 86
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 85
Screening and treatment for subclinical thyroid disease. 85
Abnormalities of left ventricular structure and function in adult patients with growth hormone deficiency. 85
NECK DISSECTION IN THE TREATMENT OF POORLY-DIFFERENTIATED CARCINOMA 85
Cytopathologists can reliably perform ultrasound-guided thyroid fine needle aspiration: a 1-year audit on 3715 consecutive cases 85
Subclinical hypothyroidism and cardiac function. 84
2007-2009 Editorial Board Member del “ Journal of Clinical Endocrinology and Metabolism”. “ 84
Valutazione degli intervalli di tempo sistolici nel follow-up post-chirurgico dei carcinomi differenziati della tiroide 84
Short-term combined treatment with L-thyroxine plus L-triiodothyronine (LT4 plus LT3) drops in patients with persistent hypothyroidism and malabsorption during replacement therapy with LT4 84
Prevalence of autoimmine thyroiditis In an Italian multiple sclerosis cohort 84
Endogenous subclinical hyperthyropidism affects quality of life and cardiac morphology and function iin young and middle-aged patients. 83
Growth hormone and heart performance: a novel mechanism of cardiac wall stress regulation in humans. 83
Effetti dell'ipotiroidismo acuto sul cuore. 83
Patients with Subclinical Cushing’s Syndrome due to Adrenal Adenoma have increased Cardiovascular risk. 82
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. 82
Editorial Board 82
American Thyroid Association 82
Strong association between an HLA antigen and medullary thyroid carcinoma 82
Recenti tecniche diagnostiche nel follow-up post chirurgico del carcinoma midollare della tiroide (CMT): cateterizzazione venosa selettiva (CVS) e scintigrafia con 131 I metaiodobenzilguanidina (131 I MIBG). 82
Aldosterone receptors' blockade in the management of heart failure in elderly patients 81
Bilateral pheocromocitytoma, papillary thyroid carcinoma and C-cell hyperplasia in a patient affected by a germline TMEM-127 mutation” 81
Aldosterone receptor blockade in the management of heart failure. 80
Recombinant human thyrotropin reduces serum vascular endothelial growth factor levels in patients monitored for thyroid carcinoma even in the absence of thyroid tissue. 80
Diastolic dysfunction in patients on TSH-suppressive therapy with levo-thyroxine: effect of beta-blockade. 79
Effetti sul cuore della terapia tireosoppressiva a lungo termine. 79
Long-term growth hormone deficiency as a cause of cardiomyopathy and its reversibility with specific replacement therapy 79
Totale 11.086
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.436 0 0 4 15 27 66 12 70 292 68 150 732
2022/20231.371 324 62 19 118 151 166 13 130 198 103 56 31
2023/2024979 41 125 61 38 57 43 13 89 25 38 243 206
2024/20256.423 462 671 36 61 101 169 721 312 881 652 1.702 655
2025/202611.013 1.314 797 918 824 1.712 422 1.316 771 1.679 671 275 314
2026/20271.608 350 895 363 0 0 0 0 0 0 0 0 0
Totale 25.866